Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PARL pseudogene 1 (PARLP1) is a pseudogene annotated in the human genome. It is also referred to as "presenilin associated rhomboid like pseudogene." Unlike protein-coding genes, pseudogenes such as PARLP1 do not encode functional proteins and are generally regarded as non-functional genetic elements, though in some contexts pseudogenes may have regulatory or evolutionary roles. There is currently no evidence that PARLP1 encodes a functional product, nor is it considered a therapeutic target. No disease associations, biological functions, or drug interactions have been attributed to this pseudogene[5]. #### Key details: - **PARL pseudogene 1 (PARLP1)** is distinct from the protein-coding gene "Presenilin associated rhomboid like" (PARL), which is a mitochondrial serine protease involved in apoptosis and is considered a potential therapeutic target[1][2]. However, **PARLP1 itself is a non-coding pseudogene**[5]. - **is_incorrect:** set to true because this entry may be mistaken for the functional "PARL" protein-coding gene, which does have biological and therapeutic relevance; PARLP1 (being a pseudogene) does not[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PARL pseudogene 1 (PARLP1).